Northwestern Mutual Wealth Management’s Vor Biopharma VOR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13	Closed	-$773	–	3547
2023 Q2	$773	Hold	13	–	–	﹤0.01%	3123
2023 Q1	$1.34K	Hold	13	–	–	﹤0.01%	2983
2022 Q4	$1.66K	Hold	13	–	–	﹤0.01%	2984
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	3031
2022 Q2	$1K	Hold	13	–	–	﹤0.01%	3094
2022 Q1	$2K	Hold	13	–	–	﹤0.01%	2939
2021 Q4	$3K	Hold	13	–	–	﹤0.01%	2906
2021 Q3	$4K	Buy	+13	New	+$3.86K	﹤0.01%	2741

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Northwestern Mutual Wealth Management's VOR Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Vor Biopharma (VOR) in Q3 2023, closing a stake of 13 shares — an estimated $773 sold.

Northwestern Mutual Wealth Management first reported a position in VOR in Q3 2021 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 59 funds tracked by Wall St. Rank hold VOR as of Q3 2023.

Northwestern Mutual Wealth Management reported no remaining Vor Biopharma position as of Q3 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 13 Vor Biopharma shares in Q3 2023, an estimated $773.
Northwestern Mutual Wealth Management first reported a position in Vor Biopharma in Q3 2021 and held it in 8 quarters.
Northwestern Mutual Wealth Management's Vor Biopharma position peaked at $4K in Q3 2021.
59 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.